自然周期冻融胚胎移植中黄体期支持补充孕酮的效果:基于随机对照试验的系统评价与Meta分析
该系统评价与Meta分析纳入4项RCT共1116例患者,评估自然周期冻融胚胎移植中补充孕酮行黄体期支持对生殖结局的影响。结果显示补充孕酮与活产率(RR 1.42,95%CI 1.15-1.75)和临床妊娠率(RR 1.30,95%CI 1.07-1.57)升高相关,证据质量中等;亚组分析显示真自然周期中相关,改良自然周期中未发现关联。
要点
- 补充孕酮与自然周期冻融胚胎移植活产率升高相关(RR 1.42,95%CI 1.15-1.75,中等质量证据)。
- 补充孕酮与临床妊娠率升高相关(RR 1.30,95%CI 1.07-1.57,中等质量证据)。
- 真自然周期中补充孕酮与活产率和临床妊娠率升高相关,改良自然周期中未发现关联。
核心结论
- 中等质量证据提示自然周期冻融胚胎移植中补充孕酮行黄体期支持与活产率和临床妊娠率升高相关。
- 真自然周期中补充孕酮与活产率和临床妊娠率升高相关。
- 改良自然周期中补充孕酮的有效性需更大样本RCT进一步验证。
- 低至极低质量证据提示改良自然周期中口服地屈孕酮与阴道孕酮生殖结局相似,需进一步研究,尤其在真自然周期中。
研究设计与样本
- 系统评价与Meta分析,检索PubMed、Ovid-Embase、Cochrane Library、Web of Science、CNKI、万方、维普和CBM,检索时间从建库至2022年9月。
- 纳入在自然周期冻融胚胎移植中行黄体期支持使用孕酮的RCT,包括真自然周期和改良自然周期。
- 共纳入4项RCT,涉及1116例参与者。
- 以相对风险(RR)为效应量统计量,各效应量给出95%置信区间(CI)。
主要发现
- 补充孕酮与活产率升高相关(RR 1.42,95%CI 1.15-1.75;I²=0%,中等质量证据)。
- 补充孕酮与临床妊娠率升高相关(RR 1.30,95%CI 1.07-1.57;I²=0%,中等质量证据)。
- 亚组分析显示真自然周期中补充孕酮与活产率和临床妊娠率升高相关。
- 改良自然周期中未发现补充孕酮与活产率和临床妊娠率升高的关联。
- 仅1项RCT报告改良自然周期中口服地屈孕酮与阴道孕酮相比临床妊娠率和流产率相似。
关键数值与推荐
- 主要结局为活产率和临床妊娠率,次要结局为流产率。
- 真自然周期亚组中补充孕酮与活产率和临床妊娠率升高相关,改良自然周期亚组中未发现关联。
- 低至极低质量证据提示改良自然周期中口服地屈孕酮与阴道孕酮生殖结局相似,需进一步研究。
局限性
- 原文结论指出自然周期冻融胚胎移植中黄体期支持补充孕酮的必要性有待进一步确认。
- 原文结论指出改良自然周期中补充孕酮的有效性需更大样本RCT进一步验证。
- 原文结论指出口服地屈孕酮与阴道孕酮生殖结局相似这一低至极低质量证据需进一步研究,尤其在真自然周期中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The necessity of progesterone supplementation for luteal phase support (LPS) in natural cycle frozen embryo transfer (NC-FET) cycles warrants further confirmation. OBJECTIVE: To investigate the effect of progesterone supplementation for LPS on the reproductive outcomes of patients undergoing NC-FET cycles. DATA SOURCES: The PubMed, Ovid-Embase, Cochrane Library, Web of Science, CNKI, Wanfang, VIP, and CBM were electronically searched. The search time frame was from inception up to September 2022. STUDY SELECTION AND SYNTHESIS: Randomized controlled trials (RCTs) that used progesterone for LPS in NC-FET cycles, including true NC-FET cycles (tNC-FET) and modified NC-FET cycles (mNC-FET), were included. The counted data were analyzed using relative risk (RR) as the effect-size statistic, and each effect size was assigned its 95% confidence interval (CI). MAIN OUTCOME MEASURES: The primary outcomes were the live birth rate (LBR) and the clinical pregnancy rate (CPR), and the secondary outcome was the miscarriage rate. RESULTS: Four RCTs were included, which involved 1116 participants. The results of the meta-analysis showed that progesterone supplementation was associated with increased LBR (RR, 1.42; 95% CI, 1.15-1.75; I2 = 0%, moderate-quality evidence) and CPR (RR, 1.30, 95% CI, 1.07-1.57; I2 = 0%, moderate-quality evidence) in patients undergoing NC-FET cycles. Subgroup analysis showed that progesterone supplementation was associated with higher LBR and CPR in tNC-FET cycles. However, no association was found between increased LBR and CPR in mNC-FET cycles. In addition, only one RCT reported that oral dydrogesterone had similar CPR and miscarriage rate compared with vaginal progesterone in mNC-FET cycles. CONCLUSION(S): Overall, moderate-quality evidence suggested that progesterone supplementation for LPS was associated with increased LBR and CPR in NC-FET cycles. Progesterone supplementation was associated with a higher LBR and CPR in tNC-FET cycles. However, the effectiveness of progesterone supplementation in mNC-FET cycles should be further verified by larger RCTs. Low to very low-quality evidence indicated that oral dydrogesterone and vaginal progesterone have similar reproductive outcomes in mNC-FET cycles, which requires further study, especially in tNC-FET cycles. REGISTRATION NUMBER: PROSPERO CRD42022355550 (https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=355550) was registered on September 3, 2022.
引用
- Jiang Y, Wang L, Shen H, et al. The effect of progesterone supplementation for luteal phase support in natural cycle frozen embryo transfer: a systematic review and meta-analysis based on randomized controlled trials. Fertil Steril. 2022. PMID: 36574915. doi:10.1016/j.fertnstert.2022.12.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。